IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152 | +28.8% | 33,528 | +100.0% | 0.00% | -100.0% |
| Q2 2023 | $118 | +15.7% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $102 | -4.7% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $107 | -99.9% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $161,000 | -13.0% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $185,000 | -33.7% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $279,000 | -12.8% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $320,000 | -22.5% | 16,764 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $413,000 | -5.3% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $436,000 | -17.9% | 16,764 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $531,000 | -31.7% | 16,764 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $778,000 | +26.3% | 16,764 | -10.4% | 0.00% | +33.3% |
| Q3 2020 | $616,000 | +20.1% | 18,701 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $513,000 | -8.4% | 18,701 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $560,000 | +8.1% | 18,701 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $518,000 | +52.4% | 18,701 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $340,000 | -25.9% | 18,701 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $459,000 | – | 18,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |